Guo BF - Search Results

1

Plasmid-based Stat3 siRNA delivered by hydroxyapatite nanoparticles suppresses mouse prostate tumour growth in vivo.

Liang ZW, Guo BF, Li Y, Li XJ, Li X, Zhao LJ, Gao LF, Yu H, Zhao XJ, Zhang L, Yang BX. Liang ZW, et al. Among authors: guo bf. Asian J Androl. 2011 May;13(3):481-6. doi: 10.1038/aja.2010.167. Epub 2011 Feb 7. Asian J Androl. 2011. PMID: 21297658 Free PMC article.

2

Intratumoral delivery and suppression of prostate tumor growth by attenuated Salmonella enterica serovar typhimurium carrying plasmid-based small interfering RNAs.

Zhang L, Gao L, Zhao L, Guo B, Ji K, Tian Y, Wang J, Yu H, Hu J, Kalvakolanu DV, Kopecko DJ, Zhao X, Xu DQ. Zhang L, et al. Cancer Res. 2007 Jun 15;67(12):5859-64. doi: 10.1158/0008-5472.CAN-07-0098. Cancer Res. 2007. PMID: 17575154

3

Bacterial delivery of siRNAs: a new approach to solid tumor therapy.

Xu DQ, Zhang L, Kopecko DJ, Gao L, Shao Y, Guo B, Zhao L. Xu DQ, et al. Methods Mol Biol. 2009;487:161-87. doi: 10.1007/978-1-60327-547-7_8. Methods Mol Biol. 2009. PMID: 19301647

4

Inhibition of tumor growth and induction of apoptosis in prostate cancer cell lines by overexpression of tissue inhibitor of matrix metalloproteinase-3.

Zhang L, Zhao L, Zhao D, Lin G, Guo B, Li Y, Liang Z, Zhao XJ, Fang X. Zhang L, et al. Cancer Gene Ther. 2010 Mar;17(3):171-9. doi: 10.1038/cgt.2009.59. Epub 2009 Oct 2. Cancer Gene Ther. 2010. PMID: 19798124

5

Is XMRV a causal virus for prostate cancer?

Zhang ZZ, Guo BF, Feng Z, Zhang L, Zhao XJ. Zhang ZZ, et al. Among authors: guo bf. Asian J Androl. 2011 Sep;13(5):698-701. doi: 10.1038/aja.2011.32. Epub 2011 Jul 18. Asian J Androl. 2011. PMID: 21765437 Free PMC article. Review.

6

Effects of a human plasma membrane-associated sialidase siRNA on prostate cancer invasion.

Li X, Zhang L, Shao Y, Liang Z, Shao C, Wang B, Guo B, Li N, Zhao X, Li Y, Xu D. Li X, et al. Biochem Biophys Res Commun. 2011 Dec 16;416(3-4):270-6. doi: 10.1016/j.bbrc.2011.11.001. Epub 2011 Nov 10. Biochem Biophys Res Commun. 2011. PMID: 22093819

7

Antitumor effects of Stat3-siRNA and endostatin combined therapies, delivered by attenuated Salmonella, on orthotopically implanted hepatocarcinoma.

Jia H, Li Y, Zhao T, Li X, Hu J, Yin D, Guo B, Kopecko DJ, Zhao X, Zhang L, Xu DQ. Jia H, et al. Cancer Immunol Immunother. 2012 Nov;61(11):1977-87. doi: 10.1007/s00262-012-1256-y. Epub 2012 Apr 18. Cancer Immunol Immunother. 2012. PMID: 22527247 Free PMC article.

8

Targeted therapy via oral administration of attenuated Salmonella expression plasmid-vectored Stat3-shRNA cures orthotopically transplanted mouse HCC.

Tian Y, Guo B, Jia H, Ji K, Sun Y, Li Y, Zhao T, Gao L, Meng Y, Kalvakolanu DV, Kopecko DJ, Zhao X, Zhang L, Xu D. Tian Y, et al. Cancer Gene Ther. 2012 Jun;19(6):393-401. doi: 10.1038/cgt.2012.12. Epub 2012 May 4. Cancer Gene Ther. 2012. PMID: 22555509 Free PMC article.

9

Plasmid-based Survivin shRNA and GRIM-19 carried by attenuated Salmonella suppresses tumor cell growth.

Liu YB, Zhang L, Guo YX, Gao LF, Liu XC, Zhao LJ, Guo BF, Zhao LJ, Zhao XJ, Xu DQ. Liu YB, et al. Among authors: guo bf, guo yx. Asian J Androl. 2012 Jul;14(4):536-45. doi: 10.1038/aja.2011.179. Epub 2012 May 14. Asian J Androl. 2012. PMID: 22580637 Free PMC article.

10

Functional graphene oxide as a plasmid-based Stat3 siRNA carrier inhibits mouse malignant melanoma growth in vivo.

Yin D, Li Y, Lin H, Guo B, Du Y, Li X, Jia H, Zhao X, Tang J, Zhang L. Yin D, et al. Nanotechnology. 2013 Mar 15;24(10):105102. doi: 10.1088/0957-4484/24/10/105102. Epub 2013 Feb 20. Nanotechnology. 2013. PMID: 23425941

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters